<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39835015</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Tingling, Numbness, and Underlying Malignancy: A Case Report of Glioblastoma Multiforme.</ArticleTitle><Pagination><StartPage>e76081</StartPage><MedlinePgn>e76081</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e76081</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.76081</ELocationID><Abstract><AbstractText>Glioblastoma multiforme (GBM) is a World Health Organisation (WHO) grade IV glioma originating from astrocytes. It is the most common malignant primary tumour of the brain and central nervous system (CNS) and is associated with&#xa0;fast progression and violent local spread, with a median overall survival of approximately 15 months after diagnosis.&#xa0;Due to its late and varied presentation, it is often diagnosed only after it has grown considerably. The symptomatology can vary from the individual being completely asymptomatic to mild sensory or sensorimotor symptoms. The symptoms usually arise due to compression of the fibres rather than pressure on vital structures.&#xa0; We discuss a case of a 72-year-old male who presented with complaints of tingling in the left upper limb for one day, improving spontaneously. A noncontrast CT head was nondiagnostic, and an MRI reported a likely metastatic lesion, and&#xa0;further imaging&#xa0;was advised. A detailed history was taken from an oncology point of view but the patient denied any weight loss, fever, recent travel, and family history of cancers. The scans were discussed at a neuroradiology multidisciplinary team&#xa0;(MDT) discussion an MRI with contrast was planned. After a thorough discussion and further review by neuroradiology consultants, the patient was diagnosed with a grade IV glioblastoma - a primary tumour of the brain - which was confirmed by a biopsy and immunohistochemistry. He was treated with two cycles of radiotherapy initially, followed by chemotherapy. Unfortunately, he died eight months after the start of the treatment due to a massive pulmonary embolism, complicated by nosocomial infection. This report highlights the importance of early diagnosis and treatment&#xa0;for patients with glioma. It also sheds light on the symptomatology and difficulties faced in the diagnosis of gliomas. Treating physicians should adopt an MDT approach in such cases and discuss the various possibilities and differentials.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Bhatia et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhatia</LastName><ForeName>Ritika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>General Medicine, Dartford and Gravesham NHS Trust, Dartford, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Himanshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>General Medicine, Chelsea and Westminster NHS Foundation Trust, London, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadeque</LastName><ForeName>Jafor</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>General Medicine, Dartford and Gravesham NHS Trust, Dartford, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathur</LastName><ForeName>Kushagra</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>General Medicine, Dartford and Gravesham NHS Trust, Dartford, GBR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diagnostic dilenna</Keyword><Keyword MajorTopicYN="N">glioblastoma tumour</Keyword><Keyword MajorTopicYN="N">intracerebral mass</Keyword><Keyword MajorTopicYN="N">intracerebral metastasis</Keyword><Keyword MajorTopicYN="N">neurology and neuro-oncology</Keyword></KeywordList><CoiStatement>Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>21</Day><Hour>9</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>21</Day><Hour>9</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>21</Day><Hour>4</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39835015</ArticleId><ArticleId IdType="pmc">PMC11743905</ArticleId><ArticleId IdType="doi">10.7759/cureus.76081</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Improved survival time trends for glioblastoma using the SEER 17 population-based registries. Koshy M, Villano JL, Dolecek TA, et al. J Neurooncol. 2012;107:207&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4077033</ArticleId><ArticleId IdType="pubmed">21984115</ArticleId></ArticleIdList></Reference><Reference><Citation>Survival comparison between glioblastoma multiforme and other incurable cancers. Tran B, Rosenthal MA. J Clin Neurosci. 2010;17:417&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">20167494</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology of glioblastoma multiforme-literature review. Grochans S, Cybulska AM, Simi&#x144;ska D, Korbecki J, Kojder K, Chlubek D, Baranowska-Bosiacka I. Cancers (Basel) 2022;14:16&#x2013;18.</Citation></Reference><Reference><Citation>Glioblastoma in England: 2007-2011. Brodbelt A, Greenberg D, Winters T, Williams M, Vernon S, Collins VP. Eur J Cancer. 2015;51:533&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pubmed">25661102</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973-2014. Li K, Lu D, Guo Y, Wang C, Liu X, Liu Y, Liu D. Cancer Med. 2018;7:5281&#x2013;5290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6198197</ArticleId><ArticleId IdType="pubmed">30175510</ArticleId></ArticleIdList></Reference><Reference><Citation>Survivorship in adults with malignant brain and other central nervous system tumor from 2000-2014. Gittleman H, Boscia A, Ostrom QT, Truitt G, Fritz Y, Kruchko C, Barnholtz-Sloan JS. Neuro Oncol. 2018;20:0.</Citation></Reference><Reference><Citation>Kanderi T, Munakomi S, Gupta V. Treasure Island, FL: StatPearls Publishing; 2024. Glioblastoma Multiforme.</Citation></Reference><Reference><Citation>Atypical presentation of glioblastoma multiforme. Al-Janabi W, Krebs R, Arcila-Londono X, Zaman I, Ahmad BK. Eur J Case Rep Intern Med. 2018;5:954.</Citation></Reference><Reference><Citation>Rapid progression of glioblastoma multiforme: a case report. Zhang YY, Ruan LX, Zhang S. Oncol Lett. 2016;12:4803&#x2013;4806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5228339</ArticleId><ArticleId IdType="pubmed">28105188</ArticleId></ArticleIdList></Reference><Reference><Citation>Unusual manifestations of primary glioblastoma multiforme: a report of three cases. Sanli AM, Turkoglu E, Dolgun H, Sekerci Z. Surg Neurol Int. 2010;1:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3011111</ArticleId><ArticleId IdType="pubmed">21206896</ArticleId></ArticleIdList></Reference><Reference><Citation>Atypical presentation of frontal lobe tumor (glioblastoma) in an adolescent: a case report. Ekezie J, Fawol R, Manwani S. J Sci Innov Med. 2021;4:2&#x2013;4.</Citation></Reference><Reference><Citation>Atypical presentation of glioblastoma: a case report. Isaac T, Mansour N. Cureus. 2024;16:0.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>